Clinical Trial Update: The Influence of Secretin Stimulated Pancreatic Secretion on ctDNA Expression in Patients With Pancreatic Ductal Adenocarcinoma: The Role of Biomarkers in Determining the Prognosis of Pancreatic Ductal Adenocarcinoma

View source ↗

Summary

This clinical trial update from Charles University investigates whether secretin-stimulated pancreatic secretion affects ctDNA expression in pancreatic ductal a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer

Snippet

Sponsor: Charles University, Czech Republic | Conditions: Pancreatic Adenocarcinoma, Pancreatic Cancer | Status: NOT_YET_RECRUITING